Calling my network: Looking for a Product or Founder background for a GM role. Must be AI-native. Must be very into Longevity. Working on something new...
FDA proposes to exclude semaglutide, tirzepatide, and liraglutide on the 503B bulks list. After careful review, we did not identify sufficient clinical need for outsourcing facilities to compound these drugs from bulk substances. Public comment period now open. Learn more: https://t.co/LI4W0YXTye
@brycestrauss@Jason_A_Scharf I'm totally in agreement with that. However most applied AI eng or founders are in their early/mid 20s... maybe a generalist statement but most aren't parents.
4/ AI doesn't fix broken architecture. It accelerates it.
The governance question for virtual care isn't coming. It's here.
I wrote my thoughts down here:
https://t.co/hRnAxHCKxI
1/ When we built Wheel, we invented the infrastructure category virtual care runs on. Enterprises, health plans, clinicians... all standing on what we built.
That's not a founding story. That's weight.
3/ But pointing at what's broken was never Wheel's role.
Our ethos from day 1 has been to teach.
So that's what we're doing next. Bringing together the people building this right to lead the conversation.
You have no experience.
You’ve never started a company.
You’ve never had a full time job.
Nike is going to kill you.
You’re a kid.
You don’t have technical skills.
You shouldn’t build hardware.
Apple is going to kill you.
You can’t build hardware.
You can’t measure heart rate non-invasively.
Athletes don’t care about recovery.
Under Armour is going to kill you.
It won’t be accurate.
You don’t listen.
You’re an ineffective leader.
You can’t recruit great talent.
You’re going to have to pay every athlete.
You can’t measure sleep non-invasively.
It’s too expensive to research.
Athletes are a small market.
The product costs too much to make.
The product costs too much to sell.
Your valuation is too high.
Consumers aren’t going to want it.
Hardware is too hard.
You should measure steps.
Fitbit is going to kill you.
You can’t build a marketing engine.
You can’t raise enough money.
You need a real CEO.
Google is going to kill you.
You can’t be a subscription.
You can’t build a brand.
You can’t do consumer in Boston.
Your valuation is too high.
You shouldn’t make accessories.
You shouldn’t make apparel.
Lululemon is going to kill you.
You can’t predict Covid.
Stay in your niche.
You are going to run out of money.
You can’t build a health platform.
Amazon is going to kill you.
You can’t measure blood pressure.
You can’t get medical approvals.
The market is too small.
You don’t understand AI.
The market is too competitive.
It won’t work internationally.
The supply chain is too complicated.
You can’t build an AI.
You can’t raise enough money.
It’s too competitive.
Healthcare isn’t going to want it.
…
Just keep going ✌️
@chrissyfarr@healthapiguy If you count the total cost of the prescriptions you do as revenue and don't own the pharmacy, then everyone in the industry has bigger "revenue" numbers.
.@eringriffith: "His start-up, Medvi, a telehealth provider of GLP-1 weight-loss drugs, got 300 customers in its first month. In its second month, it gained 1,000 more. In 2025, Medvi’s first full year in business, the company generated $401 million in sales. Mr. Gallagher then hired his only employee, his younger brother, Elliot. This year, they are on track to do $1.8 billion in sales."
https://t.co/k00K7vlFCb